Pharmaceutical Products for CDER Research Studies - IDIQ

5/11/2026:

Questions and answers:

• Current or most recent incumbent contractor/vendor name

      Response: WE Pharma, LLC

• Previous contract number and/or SAM.gov solicitation number

      Response: Previous contract number 75F40120D00032 and solicitation number FDASOL1222072.

• Contract award value or estimated annual spend

      Response: The prior IDIQ Ceiling was $9,500,000.00.

• Historical pricing information or awarded pricing structure

      Response: Historical pricing information and awarded pricing structure are not being provided as part of this solicitation Q&A.            Requests for agency records on pricing may be submitted through the applicable FOIA process and will be reviewed for                      releasability.

• Period of performance of the incumbent contract

      Response: 9/30/2020 to 9/29/2025.

• Any publicly available award documentation or reference links

      Response: None that we are aware of.

5/4/2026: See attached amendment 1 which updates the SBCX link for the subcontracting plan.

See attached combined synopsis/solicitation.